Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2025 is 11.15% vs 16.08% in Mar 2024
Consolidate Net Profit
YoY Growth in quarter ended Mar 2025 is 9.52% vs 10.53% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2025 is 16.67% vs 17.07% in Mar 2024
Interest
YoY Growth in quarter ended Mar 2025 is 25.00% vs 60.00% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2025 has improved from Mar 2024
Compare Quarterly Results Of Biogened SA With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2025 is 12.29% vs 36.92% in Dec 2024
YoY Growth in quarter ended Mar 2025 is 11.15% vs 16.08% in Mar 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2025 is 228.57% vs 600.00% in Dec 2024
YoY Growth in quarter ended Mar 2025 is 9.52% vs 10.53% in Mar 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2025 is 833.33% vs -72.73% in Dec 2024
YoY Growth in quarter ended Mar 2025 is 16.67% vs 17.07% in Mar 2024
Quarterly - Interest
QoQ Growth in quarter ended Mar 2025 is 400.00% vs -75.00% in Dec 2024
YoY Growth in quarter ended Mar 2025 is 25.00% vs 60.00% in Mar 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2025 has improved from Dec 2024
YoY Growth in quarter ended Mar 2025 has improved from Mar 2024






